Company Overview of Taxolog, Inc.
Taxolog, Inc. designs, synthesizes, and develops taxane molecules for use in the treatment of cancer and other diseases in the United States. It offers Taxol, a taxane anti-cancer agent. The company’s products under pipeline include Milataxel IV, Milataxel Oral, Simotaxel IV, and TL-1836, 1983 for oncology treatment. It also provides programs to determine the efficacy of the less toxic analogs against diseases, such as Alzheimer's, polycystic kidney disease, psoriasis, multiple sclerosis, and rheumatoid arthritis. Taxolog, Inc. was founded in 1997 and is headquartered in Fairfield, New Jersey with an additional research facility in Tallahassee, Florida.
10 Industrial Road
Fairfield, NJ 07004
Founded in 1997
Key Executives for Taxolog, Inc.
Similar Private Companies By Industry
|ACCU-BREAK Pharmaceuticals, Inc.||United States|
|Aqua Pharmaceuticals, LLC||United States|
|Emmaus Life Sciences, Inc.||United States|
|InterHealth Nutraceuticals, Inc.||United States|
|Kali Laboratories, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Taxolog, Inc., please visit www.taxolog.com. Company data is provided by Capital IQ. Please use this form to report any data issues.